Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

RVTY vs WAT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
RVTY
Revvity, Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$11.08B
5Y Perf.-1.4%
WAT
Waters Corporation

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$22.78B
5Y Perf.+74.9%

RVTY vs WAT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
RVTY logoRVTY
WAT logoWAT
IndustryMedical - Diagnostics & ResearchMedical - Diagnostics & Research
Market Cap$11.08B$22.78B
Revenue (TTM)$2.90B$3.77B
Net Income (TTM)$241M$449M
Gross Margin51.4%55.0%
Operating Margin12.4%17.1%
Forward P/E18.4x24.3x
Total Debt$3.52B$1.41B
Cash & Equiv.$920M$588M

RVTY vs WATLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

RVTY
WAT
StockMay 20May 26Return
Revvity, Inc. (RVTY)10098.6-1.4%
Waters Corporation (WAT)100174.9+74.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: RVTY vs WAT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: WAT leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Revvity, Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
RVTY
Revvity, Inc.
The Income Pick

RVTY is the clearest fit if your priority is income & stability.

  • Dividend streak 4 yrs, beta 1.57, yield 0.3%
  • Lower P/E (18.4x vs 24.3x)
  • 0.3% yield; 4-year raise streak; the other pay no meaningful dividend
Best for: income & stability
WAT
Waters Corporation
The Growth Play

WAT carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 7.0%, EPS growth 0.5%, 3Y rev CAGR 2.1%
  • 163.2% 10Y total return vs RVTY's 87.9%
  • Lower volatility, beta 1.07, Low D/E 55.0%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthWAT logoWAT7.0% revenue growth vs RVTY's 3.7%
ValueRVTY logoRVTYLower P/E (18.4x vs 24.3x)
Quality / MarginsWAT logoWAT11.9% margin vs RVTY's 8.3%
Stability / SafetyWAT logoWATBeta 1.07 vs RVTY's 1.57
DividendsRVTY logoRVTY0.3% yield; 4-year raise streak; the other pay no meaningful dividend
Momentum (1Y)RVTY logoRVTY+9.9% vs WAT's +3.1%
Efficiency (ROA)WAT logoWAT4.6% ROA vs RVTY's 2.0%, ROIC 20.3% vs 2.7%

RVTY vs WAT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

RVTYRevvity, Inc.
FY 2025
Life Sciences
50.1%$1.4B
Diagnostics
49.9%$1.4B
WATWaters Corporation
FY 2025
Waters Instrument Systems
34.8%$1.1B
Waters Service
34.1%$1.1B
Chemistry Consumables
19.9%$631M
Ta Instrument Systems
7.7%$244M
Ta Service
3.4%$108M

RVTY vs WAT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLWATLAGGINGRVTY

Income & Cash Flow (Last 12 Months)

WAT leads this category, winning 4 of 6 comparable metrics.

WAT and RVTY operate at a comparable scale, with $3.8B and $2.9B in trailing revenue. Profitability is closely matched — net margins range from 11.9% (WAT) to 8.3% (RVTY). On growth, WAT holds the edge at +91.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricRVTY logoRVTYRevvity, Inc.WAT logoWATWaters Corporation
RevenueTrailing 12 months$2.9B$3.8B
EBITDAEarnings before interest/tax$668M$953M
Net IncomeAfter-tax profit$241M$449M
Free Cash FlowCash after capex$505M$264M
Gross MarginGross profit ÷ Revenue+51.4%+55.0%
Operating MarginEBIT ÷ Revenue+12.4%+17.1%
Net MarginNet income ÷ Revenue+8.3%+11.9%
FCF MarginFCF ÷ Revenue+17.4%+7.0%
Rev. Growth (YoY)Latest quarter vs prior year+7.0%+91.5%
EPS Growth (YoY)Latest quarter vs prior year+4.5%-142.9%
WAT leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

RVTY leads this category, winning 5 of 6 comparable metrics.

At 32.5x trailing earnings, WAT trades at a 32% valuation discount to RVTY's 47.6x P/E. On an enterprise value basis, RVTY's 20.8x EV/EBITDA is more attractive than WAT's 21.5x.

MetricRVTY logoRVTYRevvity, Inc.WAT logoWATWaters Corporation
Market CapShares × price$11.1B$22.8B
Enterprise ValueMkt cap + debt − cash$13.7B$23.6B
Trailing P/EPrice ÷ TTM EPS47.64x32.48x
Forward P/EPrice ÷ next-FY EPS est.18.37x24.30x
PEG RatioP/E ÷ EPS growth rate6.27x
EV / EBITDAEnterprise value multiple20.75x21.47x
Price / SalesMarket cap ÷ Revenue3.88x7.20x
Price / BookPrice ÷ Book value/share1.55x8.15x
Price / FCFMarket cap ÷ FCF21.80x42.21x
RVTY leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

WAT leads this category, winning 7 of 9 comparable metrics.

WAT delivers a 8.0% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $3 for RVTY. RVTY carries lower financial leverage with a 0.48x debt-to-equity ratio, signaling a more conservative balance sheet compared to WAT's 0.55x. On the Piotroski fundamental quality scale (0–9), RVTY scores 6/9 vs WAT's 4/9, reflecting solid financial health.

MetricRVTY logoRVTYRevvity, Inc.WAT logoWATWaters Corporation
ROE (TTM)Return on equity+3.3%+8.0%
ROA (TTM)Return on assets+2.0%+4.6%
ROICReturn on invested capital+2.7%+20.3%
ROCEReturn on capital employed+3.2%+18.5%
Piotroski ScoreFundamental quality 0–964
Debt / EquityFinancial leverage0.48x0.55x
Net DebtTotal debt minus cash$2.6B$820M
Cash & Equiv.Liquid assets$920M$588M
Total DebtShort + long-term debt$3.5B$1.4B
Interest CoverageEBIT ÷ Interest expense3.04x6.72x
WAT leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

WAT leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in WAT five years ago would be worth $11,311 today (with dividends reinvested), compared to $7,308 for RVTY. Over the past 12 months, RVTY leads with a +9.9% total return vs WAT's +3.1%. The 3-year compound annual growth rate (CAGR) favors WAT at 5.6% vs RVTY's -7.9% — a key indicator of consistent wealth creation.

MetricRVTY logoRVTYRevvity, Inc.WAT logoWATWaters Corporation
YTD ReturnYear-to-date+1.1%-8.5%
1-Year ReturnPast 12 months+9.9%+3.1%
3-Year ReturnCumulative with dividends-21.9%+17.9%
5-Year ReturnCumulative with dividends-26.9%+13.1%
10-Year ReturnCumulative with dividends+87.9%+163.2%
CAGR (3Y)Annualised 3-year return-7.9%+5.6%
WAT leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

WAT leads this category, winning 2 of 2 comparable metrics.

WAT is the less volatile stock with a 1.07 beta — it tends to amplify market swings less than RVTY's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricRVTY logoRVTYRevvity, Inc.WAT logoWATWaters Corporation
Beta (5Y)Sensitivity to S&P 5001.57x1.07x
52-Week HighHighest price in past year$118.30$414.15
52-Week LowLowest price in past year$81.22$275.05
% of 52W HighCurrent price vs 52-week peak+83.8%+84.4%
RSI (14)Momentum oscillator 0–10056.162.7
Avg Volume (50D)Average daily shares traded1.1M989K
WAT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

RVTY leads this category, winning 1 of 1 comparable metric.

Wall Street rates RVTY as "Buy" and WAT as "Hold". Consensus price targets imply 15.2% upside for WAT (target: $403) vs 12.9% for RVTY (target: $112). RVTY is the only dividend payer here at 0.29% yield — a key consideration for income-focused portfolios.

MetricRVTY logoRVTYRevvity, Inc.WAT logoWATWaters Corporation
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$111.86$402.57
# AnalystsCovering analysts2934
Dividend YieldAnnual dividend ÷ price+0.3%
Dividend StreakConsecutive years of raises41
Dividend / ShareAnnual DPS$0.29
Buyback YieldShare repurchases ÷ mkt cap+7.4%+0.1%
RVTY leads this category, winning 1 of 1 comparable metric.
Key Takeaway

WAT leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RVTY leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallWaters Corporation (WAT)Leads 4 of 6 categories
Loading custom metrics...

RVTY vs WAT: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is RVTY or WAT a better buy right now?

For growth investors, Waters Corporation (WAT) is the stronger pick with 7.

0% revenue growth year-over-year, versus 3. 7% for Revvity, Inc. (RVTY). Waters Corporation (WAT) offers the better valuation at 32. 5x trailing P/E (24. 3x forward), making it the more compelling value choice. Analysts rate Revvity, Inc. (RVTY) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — RVTY or WAT?

On trailing P/E, Waters Corporation (WAT) is the cheapest at 32.

5x versus Revvity, Inc. at 47. 6x. On forward P/E, Revvity, Inc. is actually cheaper at 18. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — RVTY or WAT?

Over the past 5 years, Waters Corporation (WAT) delivered a total return of +13.

1%, compared to -26. 9% for Revvity, Inc. (RVTY). Over 10 years, the gap is even starker: WAT returned +163. 2% versus RVTY's +87. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — RVTY or WAT?

By beta (market sensitivity over 5 years), Waters Corporation (WAT) is the lower-risk stock at 1.

07β versus Revvity, Inc. 's 1. 57β — meaning RVTY is approximately 47% more volatile than WAT relative to the S&P 500. On balance sheet safety, Revvity, Inc. (RVTY) carries a lower debt/equity ratio of 48% versus 55% for Waters Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — RVTY or WAT?

By revenue growth (latest reported year), Waters Corporation (WAT) is pulling ahead at 7.

0% versus 3. 7% for Revvity, Inc. (RVTY). On earnings-per-share growth, the picture is similar: Waters Corporation grew EPS 0. 5% year-over-year, compared to -13. 7% for Revvity, Inc.. Over a 3-year CAGR, WAT leads at 2. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — RVTY or WAT?

Waters Corporation (WAT) is the more profitable company, earning 20.

3% net margin versus 8. 5% for Revvity, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WAT leads at 28. 2% versus 12. 5% for RVTY. At the gross margin level — before operating expenses — WAT leads at 57. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is RVTY or WAT more undervalued right now?

On forward earnings alone, Revvity, Inc.

(RVTY) trades at 18. 4x forward P/E versus 24. 3x for Waters Corporation — 5. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WAT: 15. 2% to $402. 57.

08

Which pays a better dividend — RVTY or WAT?

In this comparison, RVTY (0.

3% yield) pays a dividend. WAT does not pay a meaningful dividend and should not be held primarily for income.

09

Is RVTY or WAT better for a retirement portfolio?

For long-horizon retirement investors, Waters Corporation (WAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

07), +163. 2% 10Y return). Revvity, Inc. (RVTY) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WAT: +163. 2%, RVTY: +87. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between RVTY and WAT?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

RVTY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

WAT

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 45%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform RVTY and WAT on the metrics below

Revenue Growth>
%
(RVTY: 7.0% · WAT: 91.5%)
Net Margin>
%
(RVTY: 8.3% · WAT: 11.9%)
P/E Ratio<
x
(RVTY: 47.6x · WAT: 32.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.